Clorox (NYSE:CLX) shares jumped more than 6% after-hours following the company’s reported Q4 results, with EPS of $1.67 coming in better than the consensus estimate of $1.16.
Revenue grew 12% year-over-year to $2 billion, beating the consensus estimate of $1.88B, driven largely by favorable price mix, partially offset by lower volume and unfavorable foreign exchange rates. Organic sales grew 14% year-over-year.
"Over the course of the year, we've been relentlessly focused on driving top-line growth while rebuilding margins in the midst of a challenging operating environment as we continue to advance our long-term strategy to invest in our advantaged portfolio of superior brands, advance our digital transformation, and streamline our operating model,” said CEO Linda Rendle.
For the full 2024 year, the company expects EPS in the range of $5.60-$5.90, compared to the consensus estimate of $5.63. Revenue is expected to grow 0-2% year-over-year. Organic sales are expected to grow in the range of 2-4%.